They found that prazosin inhibited GIC proliferation by inhibiting the PKCδ-dependent AKT signaling pathway, but rarely influenced AKT-dependent growth of neural stem cells due to a paucity of PKCδ compared with GICs.93 Taken together, these studies imply drug repurposing of prazosin holds promise for clinical cancer treatment. Here, PRKCD is linked to cancer.